1.
Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT). J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Apr. 19];6(6):s69. Available from: https://skin.dermsquared.com/skin/article/view/1825